By: J. Robijns , S. Censabella , S. Claes , L. Pannekoeke , L. Bussé , D. Colson , I. Kaminski , A. Maes MD, P. Bulens , M. Brosens , L. Noé , I. Lambrichts , A. Timmermans , V. Somers , J. Mebis MD, PhD
* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Oncology/Hemato-oncology in Belgium and Luxembourg with prescription authorisation)
** (for healthcare professionals with prescribing authorisation working outside the field of Oncology/Hemato-oncology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Oncology/Hemato-oncology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)